We firstly revealed that AFR was superior to Alb, Fib, NLR, PLR, and MLR to independently predict OS in patients with LC, especially non‐small cell lung cancer (NSCLC), and it could improve predicted efficacy of the prognostic nomogram for NSCLC. This evidence concerns the gene ALB and lung cancer.